We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 1997
BP Chemicals is acquiring Styrenix Kunststoffe, the styrene plastics business, from Veba of Germany for about £120m, which will give it extra production capacity to help it expand globally.
Harrisons & Crosfield has acquired Rheox, the US maker of additives for industrial coatings, for £280m, thereby completing its transformation into a chemicals company.
ICI has sold its International Explosives operations in Canada, Latin America and Europe, as well as its distribution businesses in the US, to Orica for £230m, which completes its exit from explosives.
Manders, the printing inks company, has agreed to a £100m acquisition by Flint Ink of the US, as it has been unable to compete with its larger international rivals.
BTP is selling its adhesives and textile coatings business to Total of France for £86m, and will use the proceeds to acquire fine chemicals companies.
ICI is to sell its methylamines business to Air Products of the US for £67m.
Peter Black Holdings has acquired Ferrosan UK, the diet supplements company, from its Danish parent for £35m.
Pfizer of the US is planning to invest £110m on the expansion of its pharmaceuticals site at Sandwich, Kent, creating 1,000 jobs.
Yule Catto is acquiring Holliday Chemical, the drugs and dyes specialist, for £255m.
Euromed, which supports a number of biomedical companies, is to go-ahead with plans to set up a biomedical business park in Bellshill, Lanarkshire, creating 150 jobs.
ICI is selling its UK fertiliser business, which includes 580 people at Billingham, to Terra Industries of the US for an initial £200m.
Cookson has sold Anzon, its fire-retardant additives business, to Great Lakes Chemical Corp of the US for £54m.
Maybridge Chemical Company of Cornwall is being acquired by a management team backed by 3i in a £20m deal.
ICI has sold ICI Forest Products, the Canadian maker of chemical products for the pulp and paper industry, to Pioneer Companies of the US for £150m, as part of its strategy to dispose of its low-margin bulk chemicals operations.
Yorkshire Group is selling its Australasian inks and pigments business to Huls America for £23m, and its UK pigments dispersions business to Holliday Chemical for £1.8m, and now plans to start looking for acquisitions.
BTP is acquiring the leather and speciality chemicals division of Yorkshire Group for £33m, allowing Yorkshire to focus on its core textile dyes business.
Burmah Castrol has acquired SMC Group, the coatings and resins company, from Chemetall for £23m, and sold Columbia Cement, the adhesives business, to TACC International of the US for $23m.
DuPont is to expand its Lycra plant in Londonderry at a cost of £78m, creating 100 jobs.
Gehe is selling the Macarthy drugs manufacturing business of Lloyds Chemists to a management team backed by Cinven, the private equity specialist, for £55.5m.
Shire Pharmaceuticals is acquiring Richwood Pharmaceuticals of Kentucky, the maker of treatments for disorders of the central nervous system, for up to £113m.
Croda International is acquiring Stoa, the French supplier of skin cream ingredients, for £40m.
Millennium Chemicals has agreed a joint venture with Lyondell Petrochemical of the US which will create a £3bn chemicals company, in order to make savings of $150m a year by eliminating duplicate overheads.
Grampian Pharmaceuticals, the animal healthcare company, is being sold to management by Grampian Holdings for £68m.
Holliday Chemical has acquired Laboratorios Julian de Mexico, the Mexican chemicals company, from SmithKline Beecham for £4.7m.
ICI has sold its titanium dioxide and polyester operations to DuPont of the US for £1.68bn in order to help fund its acquisition of Unilever's speciality chemicals business.
Ellis & Everard has acquired Mozel, the paints and coatings business based in St Louis, for £13m, as part of its strategy to expand its product range and geographical coverage.
United Drug has made a £13.6m recommended offer for Dublin Drug, the wholesaler and distributor of pharmaceutical and healthcare products.
Reflec is acquiring Plast Chemical, the powder coatings company, for up to £2.5m.
Blagden Industries has acquired Cellobond, the resins business, from BP Chemicals for £13m.
Amersham International is to merge with Nycomed of Norway to create Nycomed Amersham, a £1.1bn medical diagnostics group.
Philip Johnstone has been set up as a new company to acquire the Cementone Beaver paints and building chemicals business from Cementone for £9.5m.
Zeneca is to acquire ICI Australia's pharmaceuticals business, for a price yet to be decided.
Zeneca is acquiring Mogen International, the Dutch plant biotechnology concern, for £46m, and expects to benefit from Mogen's expertise in fungal control.
Oxford Molecular is acquiring Genetics Computer and MRL Automation, two US software companies that specialise in the development of new drugs, funded by a £30m rights issue.
ICI is acquiring Unilever's speciality chemicals division, which includes National Starch, Quest, Unichema and Crosfield, for £4.9bn, and is also discussing the sale of £3bn of its own industrial chemicals businesses including polyester, fertilisers, chlorine, explosives and pigments.
BOC has started work on a new £40m air separation plant at Teesside, which will supply oxygen and nitrogen to British Steel.
Warner Lambert has acquired PharmaChem, Hickson International's loss-making subsidiary, for £28m, thus completing the restructuring at Hickson.
Cantab Pharmaceuticals is planning to increase its range of drugs under development and will raise the number of staff from 100 to 125 with a new research facility.
BTP has acquired PCR, the US fine chemicals concern, for £44m.
Shire Pharmaceuticals is acquiring Pharmavene, the US drugs delivery concern, for up to £104m, and will make further acquisitions using funding from a £11.5m planned share offer.
ICI is acquiring the Syngas catalyst business from BASF for about £15m.
Merck is expanding its pharmaceuticals plant in Cramlington, Northumberland, in a £8.5m investment that will create 66 jobs.